| Jonathon Parker, | |
|
433 S Diamond Ranch Pkwy W, Hurricane, UT 84737-3020 | |
| (435) 635-4297 | |
| Not Available |
| Full Name | Jonathon Parker |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 433 S Diamond Ranch Pkwy W, Hurricane, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114330222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 8217987-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jonathon Parker, 1725 W 1280 N, St George, UT 84770-4273 Ph: () - | Jonathon Parker, 433 S Diamond Ranch Pkwy W, Hurricane, UT 84737-3020 Ph: (435) 635-4297 |
News Archive
GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.
Treating polycystic ovary syndrome as only a fertility condition is leaving those with the condition at greater risk of developing related long-term health conditions, according to women surveyed and interviewed in University of Warwick research.
Parent Project Muscular Dystrophy, the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne) and Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases, will collaborate on a benefit/risk study in Duchenne.
Youngsters who are allowed to leave the house without an adult are more active and enjoy a richer social life than those who are constantly supervised, according to a study conducted at UCL and reported in a special edition of the journal Built Environment (19th December).
QRxPharma Limited announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. The main findings demonstrated that QRxPharma's formulation of MoxDuo IV resulted in fewer side effects and offered better pain relief than morphine alone.
› Verified 5 days ago
Jason Davey, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 750 S 5300 W, Hurricane, UT 84737 Phone: 435-656-6664 | |
Mr. Michael Caleb Steele, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 E 2700 S, Hurricane, UT 84737 Phone: 435-635-4297 Fax: 888-866-7961 | |
Heidi Roulstone, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 654 W 375 S, Hurricane, UT 84737 Phone: 801-358-8446 | |
Adam Cheney, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 97 S 6225 W, Hurricane, UT 84737 Phone: 435-688-4427 | |
Ryan G Smith, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 617 S 700 W, Hurricane, UT 84737 Phone: 435-272-3944 | |
Brenda W Heck, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2619 W 410 N, Hurricane, UT 84737 Phone: 435-979-5227 |